Product category:
Laboratory building and design
News Release from: Cambridge Design Partnership
Edited by the Laboratorytalk Editorial
Team on 14 July 2005
Astron Clinica secures major funding
"A textbook example of how the commercial potential of university based research can be taken up by an entrepreneurial company and developed into a thriving profitable enterprise"
Astron Clinica, a spin out company from Cambridge Design Partnership (CDP), has announced a multi-million pound funding round with Kuwait Finance House (Bahrain) (KFH Bahrain) The company, which specialises in skin imaging technology, has developed a suite of non-invasive products that allow skin care specialists to identify and diagnose skin diseases including skin cancer
This article was originally published on Laboratorytalk on 24 Feb 2003 at 8.00am (UK)
Related stories
First spinal study of bone substitute
Study will measure performance of synthetic bone graft substitute in 30 patients undergoing spinal fusion for degenerative disc disease
Acquisition creates global CRO
Advanced Clinical Sciences becomes a global player in clinical research with the takeover of a Swiss CRO called CRC
For example, suspicious moles can be examined up to 2mm below the skin without painful surgery.
Astron Clinica is the first of several companies to be spun out of CDP and has, in five years, developed a healthcare business spanning three continents.
Commenting, Matt Schumann, a director with CDP, says: "Astron Clinica is a textbook example of how the commercial potential of university based research can be taken up by an entrepreneurial company and developed into a thriving profitable enterprise with world-wide sales and significant market potential.
"The fact that the company can attract investment from such a major backer is testament to Astron Clinica's market leading position".
CDP is itself a successful product development company with an international client base.
The company actively pursues a policy of developing commercially viable new technologies and applications in-house, maturing them, creating management teams, attracting funding and successfully spinning them out.
CDP is currently incubating a pipeline of other likely spin out companies in sectors as diverse as interventional cardiology, GPS, micronanotechnology and holographics.
Experience gained in developing 'next generation' products for its client base, coupled with its knowledge of creating successful spin out companies has given CDP invaluable insights into every aspect of technology business processes - from identifying likely technology solutions and potential product winners, incubating them and developing market appraisals, to creating management teams and attracting funding.
• Cambridge Design Partnership: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
